From the Introduction and Summary: "As the United States and the rest of the world rush to develop an effective vaccine and treatments for COVID-19 [coronavirus disease 2019] , it is critical that these therapies work for everyone. Unfortunately, clinical trials and research have historically prioritized white, cisgender men. Women, along with transgender men and nonbinary and gender-nonconforming people, have been excluded and underrepresented--with consequences for their health. No measures to treat and prevent the coronavirus will be truly successful if they are not effective for large swaths of the population; a failure to provide a vaccine and treatment that works for women is a failure to protect the public's health more broadly. Therefore, to better understand and address the different ways in which COVID-19 and other health conditions manifest--including but not limited to common conditions that disproportionately affect women, such as lupus and fibroids--it is critical for research and data to include women--especially women of color and pregnant women--as well as transgender men and nonbinary and gender-nonconforming people."